State-of-the-art facility planned to reinforce Medline's supply chain resilience in Michigan NORTHFI

NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP

New York, New York--(Newsfile Corp. - October 13, 2026) - The law firm of Kirby McInerney LLP contin

NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements abou

Combines real-time inventory tracking with PointClickCare® integration to reduce manual work and imp

NovoCure (NASDAQ: NVCR - Get Free Report) and Medline (NASDAQ: MDLN - Get Free Report) are both heal

Barclays analyst Glen Santangelo maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the

NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a

New York, New York--(Newsfile Corp. - October 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Medline (NASDAQ: MDLN - Get Free Report) major shareholder Private Ltd Gic sold 2,570,999 shares of

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

New York, New York--(Newsfile Corp. - October 6, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

NEW YORK--(BUSINESS WIRE)---- $MDLN #ClassActionLawsuit--The law firm of Kirby McInerney LLP reminds

NORTHFIELD, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today an

MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities F

BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements abou

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP

New York, New York--(Newsfile Corp. - October 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

UBS analyst Kevin Caliendo maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price target

FDA alerts providers as Medline corrects convenience kits with recalled BD applicators due to steril

JP Morgan analyst Lisa Gill maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the pric

Wells Fargo analyst Stephen Baxter maintains Medline (NASDAQ:MDLN) with a Equal-Weight and lowers

TD Cowen analyst Charles Rhyee maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price ta

RBC Capital analyst Ryan Halsted maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the

Truist Securities analyst Jailendra Singh maintains Medline (NASDAQ:MDLN) with a Buy and lowers t

Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform a

Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.50 per share which beat the analyst consensu

Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Allina Health

Jim Cramer says Medline is "probably" the best IPO of 2026 and expects AST SpaceMobile to be

Medline (MDLN) faces near-term headwinds after a major CA warehouse fire. William Blair analysts bre

Baird analyst Eric Coldwell maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the pric

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/m

Barclays analyst Glen Santangelo maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the

Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in t

Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Rural Medical

Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders aff

BNP Paribas analyst Navann Ty maintains Medline (NASDAQ:MDLN) with a Neutral and lowers the price

Tigress Financial analyst Ivan Feinseth maintains Medline (NASDAQ:MDLN) with a Buy and raises the

Citigroup analyst Patrick Donnelly maintains Medline (NASDAQ:MDLN) with a Buy and lowers the pric

Bernstein analyst Lee Hambright maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the

https://www.fda.gov/medical-devices/letters-health-care-providers/disruptions-availability-neurosurg

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.33 per share which beat the analyst consensu

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219163